Overview Financials News + Filings IR Vault Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Auditor change Quarterly results Director comp. Credit agrmnt [a] CC transcript Acq. announced
|
NATUS MEDICAL INC (BABY)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
03/19/2021 |
GN
| Virtual Conference for Life Sciences Companies Broadcast Live March 25th, 2021 |
01/05/2021 |
GN
| PlantX Launches Baby Products Vertical with Else Nutrition |
08/21/2019 |
GN
| Else Nutrition Holdings Inc. Shareholder Update |
07/25/2019 |
GN
| Natus Medical Announces Second Quarter 2019 Financial Results |
07/25/2019 |
GN
| Natus Medical Announces NASDAQ Ticker Symbol Change to “NTUS” |
07/11/2019 |
GN
| Natus Medical to Hold 2019 Second Quarter Financial Results Conference Call on July 25th |
05/17/2019 |
GN
| Natus to Present at William Blair 39th Annual Growth Stock Conference |
05/06/2019 |
GN
| Update to Natus Medical First Quarter 2019 Financial Results |
04/08/2019 |
GN
| Natus Medical to Hold 2019 First Quarter Financial Results Conference Call on April 25th |
04/02/2019 |
GN
| Natus Announces Sale of Medix Business |
03/29/2019 |
GN
| Bragar Eagel & Squire, P.C. is Investigating Natus Medical Incorporated (BABY) on Behalf of Stockholders and Encourages BABY Investors to Contact the Firm |
03/20/2019 |
GN
| NATUS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Natus Medical Incorporated To Contact The Firm |
02/28/2019 |
GN
| Consolidated Research: 2019 Summary Expectations for Alphabet, Aflac, Natus Medical, SPS Commerce, Semtech, and Brunswick — Fundamental Analysis, Key Performance Indications |
02/13/2019 |
GN
| Natus Medical Announces Fourth Quarter and Full Year 2018 Financial Results |
02/13/2019 |
GN
| Natus Medical Announces Continued Board Refreshment with Two New Independent Directors |
02/07/2019 |
GN
| Bragar Eagel & Squire, P.C. is Investigating Natus Medical Incorporated (BABY) on Behalf of Stockholders and Encourages BABY Investors to Contact the Firm |
02/06/2019 |
GN
| Natus Medical Inc. Investigated by Block & Leviton LLP For Violations of Federal Securities Laws |
01/28/2019 |
GN
| New Research: Key Drivers of Growth for Real Goods Solar, Standard Motor Products, Progress Software, Avon Products, Natus Medical, and Kadmon — Factors of Influence, Major Initiatives and Sustained Production |
01/02/2019 |
GN
| Natus Medical to Hold 2018 Fourth Quarter Financial Results Conference Call on February 13th |
10/24/2018 |
GN
| Natus Medical Announces Third Quarter Financial Results |
10/10/2018 |
GN
| Natus Medical to Hold 2018 Third Quarter Financial Results Conference Call on October 24th |
09/17/2018 |
GN
| Natus Appoints Drew Davies Executive Vice-President and CFO |
07/25/2018 |
GN
| Natus Medical Announces Second Quarter Financial Results |
07/11/2018 |
GN
| Natus Medical Announces Leadership Changes |
06/22/2018 |
GN
| Natus Medical Announces Preliminary Results of 2018 Annual Meeting of Stockholders |
06/21/2018 |
GN
| Investor Expectations to Drive Momentum within JBG SMITH Properties, Northwest Bancshares, Warrior Met Coal, Natus Medical, Triangle Capital, and National HealthCare — Discovering Underlying Factors of Influence |
06/14/2018 |
GN
| Natus Medical Board Announces Commitment to Governance Enhancements |
06/13/2018 |
GN
| Natus Medical Urges Shareholders to Vote FOR Natus Nominees on the WHITE Proxy Card Today |
06/11/2018 |
GN
| Natus Medical Comments on ISS Report |
06/06/2018 |
GN
| Natus Annual Meeting - What??s at Stake? |
06/04/2018 |
GN
| Natus Medical Board of Directors Mails Letter to Shareholders |
05/18/2018 |
GN
| Natus Medical Files Definitive Proxy Materials |
04/30/2018 |
GN
| Report: Developing Opportunities within Natus Medical, Aptevo Therapeutics, Revlon, Silgan, Resources Connection, and TrustCo Bank Corp NY — Future Expectations, Projections Moving into 2018 |
04/25/2018 |
GN
| Natus Medical Announces First Quarter Financial Results |
|
|
|